• Daré Bioscience set a concurrent private placement of Series A warrants, Series B warrants, and underlying common shares.
• Warrants cover up to 4,379,581 shares each series; exercise price USD 1.37 per share; exercisable only after stockholder approval.
• Series A warrants run five years from initial exercise date; Series B warrants run two years from initial exercise date.
• Closing for the registered direct offering and private placement expected on or about Aug. 17, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Dare Bioscience Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608141245PRIMZONEFULLFEED9810522) on August 14, 2026, and is solely responsible for the information contained therein.